Adapted from a press release.
BIO-CAT, Inc., a probiotic manufacturer, has agreed to partner with global distribution solutions provider Caldic North America to bring its proprietary probiotic strains and OPTIFEED-branded solutions to the companion animal health and nutrition market in North America.
BIO-CAT said the agreement secures a rapid go-to-market strategy for BIO-CAT, leveraging Caldic's leadership position in the companion animal market as a provider of value-add antioxidant, vitamin, mineral and ingredient solutions.
Founded in Keswick, Virginia, U.S., BIO-CAT is an expert in specialty enzyme and probiotic formulations. The company offers an extensive range of single-to-multi-enzyme blends and unique microbial solutions for better animal digestive health. BIO-CAT Microbials, located in Shakopee Minnesota, U.S., is BIO-CAT's vertically integrated FDA-registered and SQF-certified (human-grade) U.S. fermentation facility.
Its AAFCO-listed OPTIFEED probiotic strains are premium, safe, effective and have shown physiological benefits to companion animals in support of their gastrointestinal and digestive health. Future expansion of the OPTIFEED line of enzymes will further support digestive health, enhancing the nutritional value of pet food, and can be used in ingredient processing and flavor development.
"This partnership with BIO-CAT significantly strengthens Caldic's existing companion animal portfolio, adding a range of innovative and customizable solutions to inspire quality pet food and health." said Liz Parker, director of companion animal health & nutrition, Caldic North America. "As the importance of pet companionship is widely recognized, domestic animal owners are increasingly keen to provide their pets with nutritionally high-performing food, treats and supplements.
"The expert know-how our R&D team has acquired in pet food when formulating with our antioxidants range, Dadex, and our custom vitamin and mineral blends, Daminaide, will greatly benefit the solutions we can deliver across North America while partnering with BIO-CAT," Parker added.
Chris Schuler, president and CEO of BIO-CAT said his company's microbials' expertise in probiotic strain development and fermentation is a great match for Caldic's exceptional distribution solutions.
"We value Caldic's commitment to the companion animal space and their ability to scale our OPTIFEED probiotic business within their customer base," said Schuler. "We look forward to a successful collaboration and exclusive partnership with Caldic."
